Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Post-mortem lesions of chickens with decreased egg production in Yancheng in 2023. by Yan Wang (15435)

Summary of five key points guiding the Safe Steps evaluation and implementation. by Esario IV Daguman (21474116)

Subjects:

Table 6 - Gain and loss: Human and environmental wellbeing – drivers of Kilimanjaro’s decreasing biodiversity by Andreas Hemp (730415)

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”

SBP3 KD decreases the surface localization of VESA-1. by Atefeh Fathi (7370876)

Overexpression of EhRacM decreased dextran macropinocytosis efficiency. by Misato Shimoyama (20189888)

EGF is decreased in individual donor milk, but not pooled donor milk. by Christian Tamar (21100605)

Demonstration of decreased Aβ accumulation by DA-9601 treatment. by Mijung Lee (397790)

ROBINS-I assessments. by Martha R. Smith (20410184)

Subjects:

S8 File - by Martha R. Smith (20410184)

Subjects:

Study populations of included studies. by Martha R. Smith (20410184)

Subjects:

Future research directions. by Martha R. Smith (20410184)

Subjects:

PRISMA flow diagram. by Martha R. Smith (20410184)

Subjects:

Exercise protocols and results of included studies. by Martha R. Smith (20410184)

Subjects:

Participant characteristics in studies of children with biopsy-proven NAFLD. by Martha R. Smith (20410184)

Subjects:

S9 File - by Martha R. Smith (20410184)

Subjects:

RoB 2 assessments. by Martha R. Smith (20410184)

Subjects: